PreferredStockChannel
LifeMD Inc | 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP)

Prospectus excerpt:  We are offering for sale 1,400,000 shares of our 8.875% Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”). The liquidation preference of each share of Series A Preferred Stock is $25.00. We have granted the underwriters an option to purchase up to an additional 210,000 shares of Series A Preferred Stock within 30 days from the date of this prospectus supplement. We will pay cumulative distributions on the Series A Preferred Stock, from, and including, the date of original issuance, in the amount of $2.21875 per share each year, which is equivalent to 8.875% of the $25.00 liquidation preference per share. Dividends on the Series A Preferred Stock will be payable quarterly in arrears, on or about the 15th day of January, April, July and October of each year (or, if not on a business day, on the next succeeding business day). The first dividend on the Series A Preferred Stock sold in this offering will be paid on or about January 15, 2022. We will establish a segregated account that will be funded at closing with proceeds sufficient to pre-fund with eight (8) quarterly dividend payments. The segregated account may only be used to pay dividends on the Series A Preferred Stock, when legally permitted, and may not be used for other corporate purposes.

Full Prospectus PDF », Secondary Prospectus PDF », LFMD Page »

Series:A
Redeemable?:Yes
Call Date:10/15/2022 (Now Trading Post Call Date)
Perpetual?:Yes
Cumulative?:Yes
Shares Offered:1,400,000
Liquidation Preference:$25.00
Recent Market Price:$22.50
Discount to Liquidation Preference:
(More Preferreds Trading at a Discount »)
$-2.50 (-10.00%)
Annualized Dividend:2.21875
Recent Ex-Date:4/4/2024
Current Yield:9.86%
Original Coupon:8.875%
Pay Period:Quarterly
Pay Dates:15-Jan, 15-Apr, 15-Jul, 15-Oct
CDx3 Compliance Rating: Learn LFMDP's Rating
LifeMD is an online direct-to-patient marketing and telehealth company with various health and wellness brands. Co.'s virtual primary care offering under the LifeMD brand, LifeMD Southern Patient Medical Care, P.C., provides patients with access to a provider for their primary care, urgent care, and chronic care needs. Co. also utilizes its telehealth platform's provider network, cloud pharmacy, and electronic medical record capabilities across its direct-to-patient telehealth brands. Co.'s telehealth brands RexMD, ShapiroMD, NavaMD, and its subsidiary, Cleared Technologies, PBC, engage in their respective treatment verticals of men's health, hair loss, dermatology, and immunology.

Preferred: LFMDP


Open the LFMD Information Page »
Name: 
LifeMD Inc
Website: 
www.lifemd.com
Sector: 
Diagnostics
Number of ETFs Holding LFMD: 
6 (see which ones)
Total Market Value Held by ETFs: 
$28,083,268
Total Market Capitalization: 
$437,000,000
% of Market Cap. Held by ETFs: 
6.43%

Quotes delayed 20 minutes

Email EnvelopeFree Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Top Ten Highest Yielding Preferred Stocks
Feel-Good Income: Socially Responsible Preferreds
Dividend Channel's 25 S.A.F.E. Dividend Stocks
Increasing Payments For Decades

Safer than S.A.F.E: Preferreds of Dividend Channel's
S.A.F.E. Dividend Stocks

Recent Preferred Stock Offerings
Preferred Stocks of Dow Components
Preferred Stocks of S&P 500 Components
Preferred Stocks By Industry
Preferred Stocks Where Insiders Are Buying The Common
High Yield Preferred Stocks
Preferreds Trading At Premiums To Liquidation Preference
Preferreds Trading At Discounts To Liquidation Preference
The Top 10 DividendRank'ed U.S. Stocks
The Top 10 DividendRank'ed Canadian Stocks
Top 25 Broker Analyst Picks of the S&P 500
Stock market game

LifeMD Inc | 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) Information Page | Preferred Stock Channel | www.PreferredStockChannel.com

Copyright © 2010 - 2024, All Rights Reserved Nothing in Preferred Stock Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Preferred Stock Channel; Meet Our Editorial Staff.